Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PLXDC1 Antikörper (C-Term)

PLXDC1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB30617 unconjugated
Produktnummer ABIN1881662
  • Target Alle PLXDC1 Antikörper anzeigen
    PLXDC1 (Plexin Domain Containing 1 (PLXDC1))
    Bindungsspezifität
    • 12
    • 7
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 466-494, C-Term
    Reaktivität
    • 35
    • 6
    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 31
    • 4
    Kaninchen
    Klonalität
    • 32
    • 3
    Polyklonal
    Konjugat
    • 18
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PLXDC1 Antikörper ist unkonjugiert
    Applikation
    • 26
    • 18
    • 6
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Aufreinigung
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This PLXDC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 466-494 amino acids from the C-terminal region of human PLXDC1.
    Klon
    RB30617
    Isotyp
    Ig Fraction
    Top Product
    Discover our top product PLXDC1 Primärantikörper
  • Applikationshinweise
    WB: 1:1000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Haltbarkeit
    6 months
  • Halder, Ossendorf, Maran, Yaszemski, Bolander, Fuchs, Sarkar: "Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma." in: Anticancer research, Vol. 29, Issue 11, pp. 4317-22, (2009) (PubMed).

    Yamaji, Yoshida, Ishikawa, Sengoku, Sato, Yoshida, Kuwahara, Ohuchida, Oki, Enaida, Fujisawa, Kono, Ishibashi: "TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy." in: Investigative ophthalmology & visual science, Vol. 49, Issue 7, pp. 3151-7, (2008) (PubMed).

    Fuchs, Mahlum, Halder, Maran, Yaszemski, Bode, Bolander, Sarkar: "High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma." in: Gene, Vol. 399, Issue 2, pp. 137-43, (2007) (PubMed).

    Nanda, Buckhaults, Seaman, Agrawal, Boutin, Shankara, Nacht, Teicher, Stampfl, Singh, Vogelstein, Kinzler, St Croix: "Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R." in: Cancer research, Vol. 64, Issue 23, pp. 8507-11, (2004) (PubMed).

  • Target
    PLXDC1 (Plexin Domain Containing 1 (PLXDC1))
    Andere Bezeichnung
    PLXDC1 (PLXDC1 Produkte)
    Synonyme
    PLXDC1 antikoerper, TEM3 antikoerper, TEM7 antikoerper, 2410003I07Rik antikoerper, AI848450 antikoerper, Tem7 antikoerper, Arl12 antikoerper, plexin domain containing 1 antikoerper, PLXDC1 antikoerper, Plxdc1 antikoerper
    Hintergrund
    Plays a critical role in endothelial cell capillary morphogenesis.
    Molekulargewicht
    55760
    NCBI Accession
    NP_065138
    UniProt
    Q8IUK5
Sie sind hier:
Kundenservice